Emetrol 100ml. 200ml Oral Solution
PDF Leaflet Revision Date: 26 September 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic relief of nausea associated with gastrointestinal disorders, motion sickness, and morning sickness.
Dosage (summary)
Adults: 10-20 mL initially, repeat every 15 mins, max 5 doses/hour.
Special Populations
- Renal failure
- Diabetes
- Hereditary fructose intolerance
Pregnancy & Breastfeeding
No information available.
Contraindications
- Hypersensitivity to ingredients
- Renal failure
- Diabetes
- Hereditary fructose intolerance
Common side effects
- No side effects reported
Counselling Points
- Do not take fluids immediately before or after dosing
- Consult a doctor if nausea persists
Serious warnings
- Do not exceed 5 doses in 1 hour without consulting a doctor
- May influence glycaemia control in diabetes
Important Disclaimer
The Emetrol 100ml. 200ml Oral Solution professional information leaflet below is the property of Pharmacorp and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
Clinical Particulars
Section 4 of the official insert — extracted exactly as issued, no alterations
4.1 Therapeutic indications
EMETROL is indicated for the symptomatic relief of nausea associated with gastrointestinal disorder, motion sickness and morning sickness in early pregnancy.
4.2 Posology and method of administration
Posology
Adults: Two (2) to four (4) medicine measures (10 to 20 mL) initially. Repeat every 15 minutes until distress subsides. Do not exceed five (5) doses in one hour.
Children over 3 years of age: One (1) to two (2) medicine measures (5 to 10 mL) initially. Repeat every 15 minutes until distress subsides. Do not exceed five (5) doses in one hour.
Motion sickness (car, air, etc.):
Adults: Three (3) to six (6) medicine measures (15 to 30 mL). Repeat every 15 minutes until distress subsides. Do not exceed five (5) doses in one hour.
Morning sickness:
Three (3) to six (6) medicine measures (15 to 30 mL). Dose should be taken on arising and repeated every three hours when needed.
Method of administration
For oral use. Do not dilute since the optimal pH for functioning will be destroyed. Oral fluids should not be taken immediately before or for at least 15 minutes after the dose (see section 4.4).
4.3 Contraindications
- EMETROL is contraindicated in patients with known hypersensitivity to sucrose, phosphoric acid or any of the excipients listed in section 6.1.
- EMETROL should not be given to patients suffering from renal failure, diabetes, and hereditary fructose intolerance.
4.4 Special warnings and precautions for use
EMETROL should not be taken for more than 1 hour (5 doses) without consulting a doctor. If nausea continues or recurs, consult a doctor since this may be a sign of a serious condition.
Fluids must not be taken immediately prior to or for at least 15 minutes after a dosage of EMETROL, because of the diluting effect (see section 4.2).
Sucrose warning: EMETROL contains sucrose which may influence the glycaemia control of patients with diabetes mellitus. Patients with rare hereditary conditions such as fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltose insufficiency should not take EMETROL.
Methyl hydroxybenzoate warning: EMETROL contains methyl hydroxybenzoate as preservative. It may cause allergic reactions (possibly delayed).
4.5 Interaction with other medicines and other forms of interaction
No interaction studies have been performed.
4.6 Fertility, pregnancy and lactation
Women of childbearing potential/ Contraception in males and females
No information available.
Pregnancy
No information available.
Breastfeeding
No information available.
Fertility
No information available.
4.7 Effects on ability to drive and use machines
EMETROL has no or negligible influence on mental and/or physical abilities to perform or execute tasks or activities requiring mental alertness, judgment and/or sound coordination and vision.
4.8 Undesirable effects
EMETROL produces no side effects.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicine is important. It allows continued monitoring of the benefit/risk balance of the medicine. Healthcare providers are asked to report any suspected adverse drug reactions to SAHPRA via the Med Safety APP (Medsafety x SAHPRA) and eReporting platform (who-umc.org) found on SAHPRA website. In addition, side effects can also be reported to [email protected].
4.9 Overdose
Treatment is symptomatic and supportive.
